Randomised Study Comparing Three Chemotherapy Regimens in Non-small Cell Lung Cancer

NCT00622349 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

707

Enrollment

OTHER

Sponsor class

Conditions

Carcinoma, Non-Small-Cell Lung

Interventions

DRUG: Cisplatin, Ifosfamide, Gemcitabine
DRUG: Ifosfamide, Gemcitabine
DRUG: Cisplatin, docetaxel

Sponsor

European Lung Cancer Working Party